Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About
Home
NICE guidance
Published
Published: Guidance, quality standards and advice
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter (2 applied)
Skip to results
Keyword or reference number
Keyword or reference number
Apply filter
Last updated date
Last updated date
From date
To date
Apply date filters
Area of interest
Area of interest
Antimicrobial prescribing (23)
COVID-19 (7)
Type
(
2 selected
)
Type
Guidance (1946)
NICE advice (319)
Quality standard (198)
Guidance programme
Guidance programme
Antimicrobial prescribing guidelines (20)
Cancer service guidelines (8)
Clinical guidelines (226)
COVID-19 rapid guidelines (3)
Diagnostics guidance (50)
Health technology evaluations (26)
Highly specialised technologies guidance (30)
Interventional procedures guidance (608)
Medical technologies guidance (66)
Medicines practice guidelines (5)
NICE guidelines (337)
Public health guidelines (56)
Safe staffing guidelines (2)
Social care guidelines (70)
Technology appraisal guidance (829)
Apply filters
Showing 1 to 10 of 2144
Sort by
Date
Title
Apply sorting
Type: Guidance
Remove Type: Guidance filter
Type: Quality standard
Remove Type: Quality standard filter
Published guidance, NICE advice and quality standards
Title
Reference number
Published
Last updated
Dostarlimab with platinum-based chemotherapy for treating primary advanced or recurrent endometrial cancer with high microsatellite instability or mismatch repair deficiency
TA1064
22 May 2025
22 May 2025
Capivasertib with fulvestrant for treating hormone receptor-positive HER2-negative advanced breast cancer after endocrine treatment
TA1063
15 May 2025
15 May 2025
Erdafitinib for treating unresectable or metastatic urothelial cancer with FGFR3 alterations after a PD-1 or PD-L1 inhibitor
TA1062
12 May 2025
12 May 2025
Osimertinib with pemetrexed and platinum-based chemotherapy for untreated EGFR mutation-positive advanced non-small-cell lung cancer
TA1060
8 May 2025
8 May 2025
Brentuximab vedotin in combination for untreated stage 3 or 4 CD30-positive Hodgkin lymphoma
TA1059
7 May 2025
7 May 2025
Digital therapy for chronic tic disorders and Tourette syndrome: early value assessment
HTE25
7 May 2025
7 May 2025
Omaveloxolone for treating Friedreich's ataxia in people 16 years and over (terminated appraisal)
TA1061
6 May 2025
6 May 2025
Drug-eluting stents for treating coronary artery disease: late-stage assessment
HTE26
6 May 2025
6 May 2025
Cenobamate for treating focal onset seizures in epilepsy
TA753
15 December 2021
6 May 2025
Artificial intelligence (AI) technologies for assessing and triaging skin lesions referred to the urgent suspected skin cancer pathway: early value assessment
HTE24
1 May 2025
1 May 2025
Current page
1
2
3
…
215
Page
1
of
215
Next page
Results per page
10
25
50
All
Back to top